276 related articles for article (PubMed ID: 19127598)
1. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
Swami S; Krishnan AV; Moreno J; Bhattacharyya RS; Gardner C; Brooks JD; Peehl DM; Feldman D
Int J Cancer; 2009 May; 124(9):2050-9. PubMed ID: 19127598
[TBL] [Abstract][Full Text] [Related]
2. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.
Moreno J; Krishnan AV; Swami S; Nonn L; Peehl DM; Feldman D
Cancer Res; 2005 Sep; 65(17):7917-25. PubMed ID: 16140963
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.
Krishnan AV; Feldman D
Endocr Relat Cancer; 2010 Mar; 17(1):R19-38. PubMed ID: 19926709
[TBL] [Abstract][Full Text] [Related]
4. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
[TBL] [Abstract][Full Text] [Related]
5. Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP.
Payton-Stewart F; Schoene NW; Kim YS; Burow ME; Cleveland TE; Boue SM; Wang TT
Mol Carcinog; 2009 Sep; 48(9):862-71. PubMed ID: 19263441
[TBL] [Abstract][Full Text] [Related]
6. Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells.
Handayani R; Rice L; Cui Y; Medrano TA; Samedi VG; Baker HV; Szabo NJ; Shiverick KT
J Nutr; 2006 Jan; 136(1):75-82. PubMed ID: 16365062
[TBL] [Abstract][Full Text] [Related]
7. Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer.
Swami S; Krishnan AV; Moreno J; Bhattacharyya RB; Peehl DM; Feldman D
J Nutr; 2007 Jan; 137(1 Suppl):205S-210S. PubMed ID: 17182827
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway.
Moreno J; Krishnan AV; Peehl DM; Feldman D
Anticancer Res; 2006; 26(4A):2525-30. PubMed ID: 16886660
[TBL] [Abstract][Full Text] [Related]
9. Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells.
Rice L; Handayani R; Cui Y; Medrano T; Samedi V; Baker H; Szabo NJ; Rosser CJ; Goodison S; Shiverick KT
J Nutr; 2007 Apr; 137(4):964-72. PubMed ID: 17374662
[TBL] [Abstract][Full Text] [Related]
10. Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells.
Davis JN; Singh B; Bhuiyan M; Sarkar FH
Nutr Cancer; 1998; 32(3):123-31. PubMed ID: 10050261
[TBL] [Abstract][Full Text] [Related]
11. Soy isoflavones in the treatment of prostate cancer.
Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
[TBL] [Abstract][Full Text] [Related]
12. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer.
Chen Y; Zaman MS; Deng G; Majid S; Saini S; Liu J; Tanaka Y; Dahiya R
Cancer Prev Res (Phila); 2011 Jan; 4(1):76-86. PubMed ID: 21071579
[TBL] [Abstract][Full Text] [Related]
14. 3,3'-Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cells.
Smith S; Sepkovic D; Bradlow HL; Auborn KJ
J Nutr; 2008 Dec; 138(12):2379-85. PubMed ID: 19022961
[TBL] [Abstract][Full Text] [Related]
15. Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer.
Bilir B; Sharma NV; Lee J; Hammarstrom B; Svindland A; Kucuk O; Moreno CS
Int J Oncol; 2017 Jul; 51(1):223-234. PubMed ID: 28560383
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components.
Zhou JR; Yu L; Zhong Y; Nassr RL; Franke AA; Gaston SM; Blackburn GL
Prostate; 2002 Oct; 53(2):143-53. PubMed ID: 12242729
[TBL] [Abstract][Full Text] [Related]
17. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor-β mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones.
Bielecki A; Roberts J; Mehta R; Raju J
Nutr Cancer; 2011; 63(1):139-50. PubMed ID: 21161820
[TBL] [Abstract][Full Text] [Related]
19. Soy isoflavones and prostate cancer: a review of molecular mechanisms.
Mahmoud AM; Yang W; Bosland MC
J Steroid Biochem Mol Biol; 2014 Mar; 140():116-32. PubMed ID: 24373791
[TBL] [Abstract][Full Text] [Related]
20. Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy.
Singh-Gupta V; Zhang H; Yunker CK; Ahmad Z; Zwier D; Sarkar FH; Hillman GG
Pharm Res; 2010 Jun; 27(6):1115-27. PubMed ID: 20309614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]